Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Nov 03, 2021 11:07am
178 Views
Post# 34082158

RE:RE:RE:Enters into a Cooperation Agreement

RE:RE:RE:Enters into a Cooperation Agreementaccchhh,,there is very little detail in such a NR,because our team really has no idea what a cooperation agreement is. Probably that they wont make fun of our attemts at trying to push this pill forward. Hahahaha....incredible nonsense being dispersed by a fellow who seems to be suffering from dementia. I had hoped DMcC was in the Montreal Cognitive trial to assess general mental ability and and if its in decline. But ,,nope,,,,,we continue to get these ambiguous mealy mouthed blurbs that send our share price into free fall.  There is undoubtedly lots of shares out there to be flushed at any attempt to move up than there are buyers in wait for the long haul. jmo,,based on years and years and more years of, uninary track excretion, poor management.
<< Previous
Bullboard Posts
Next >>